Laval University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Laval University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10700
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laval University is an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate, degree programs and distance education programs. It offers courses in the fields of advanced international studies, agriculture and food sciences, arts and human sciences, business administration, dentistry and education. Laval University also provides courses in the fields of forestry, geography and geomatics, graduate and postdoctoral studies, law, medicine, music, nursing, pharmacy, philosophy, science and engineering, social sciences and theology and religious studies. The institute operates interdisciplinary institutes, research centers, international mixed units, mixed research unit and others. Laval University is headquartered in Quebec City, Quebec, Canada.

Laval University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laval University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laval University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laval University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laval University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laval University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laval University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AmorChem Enters into Co-Development Agreement with Universite Laval and CHU De Quebec 10
Roche Enters Into Research Agreement With Laval University 11
AmorChem Enters Into Co-Development Agreement With Universite Laval And CHU De Quebec 12
Licensing Agreements 13
Signia Therapeutics Enters into Licensing Agreement with University Claude Bernard of Lyon and Laval University 13
Microlin Bio Enters into Licensing Agreement with Universite Laval 14
Raptor Pharma Enters Into Licensing Agreement With Universite Laval For IP Rights Related To Parkinson’s Disease 15
Laval University – Key Competitors 16
Laval University – Key Employees 17
Laval University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Feb 19, 2018: Government of Canada and Brain Canada announce a $10-million grant to establish a platform that will help researchers share data more widely and efficiently 19
Aug 21, 2017: The Government of Canada invests over $21M in innovative health research 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Laval University, Pharmaceuticals & Healthcare, Key Facts 2
Laval University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laval University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laval University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laval University, Deals By Therapy Area, 2012 to YTD 2018 8
Laval University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AmorChem Enters into Co-Development Agreement with Universite Laval and CHU De Quebec 10
Roche Enters Into Research Agreement With Laval University 11
AmorChem Enters Into Co-Development Agreement With Universite Laval And CHU De Quebec 12
Signia Therapeutics Enters into Licensing Agreement with University Claude Bernard of Lyon and Laval University 13
Microlin Bio Enters into Licensing Agreement with Universite Laval 14
Raptor Pharma Enters Into Licensing Agreement With Universite Laval For IP Rights Related To Parkinson's Disease 15
Laval University, Key Competitors 16
Laval University, Key Employees 17
Laval University, Subsidiaries 18

List of Figures
Laval University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laval University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laval University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laval University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laval University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laval University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laval University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laval University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Laval University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Boule Diagnostics AB (BOUL):企業の財務・戦略的SWOT分析
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • Tokuyama Corporation (4043)-エネルギー分野:企業M&A・提携分析
    Summary Tokuyama Corporation (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, me …
  • Cargill Inc:企業の戦略的SWOT分析
    Cargill Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Nexstim Plc (NXTMH):企業の財務・戦略的SWOT分析
    Nexstim Plc (NXTMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • CPI Aerostructures, Inc.:企業の戦略・SWOT・財務分析
    CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report Summary CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nordstrom, Inc.:企業の戦略・SWOT・財務情報
    Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Atara Biotherapeutics Inc (ATRA):企業の財務・戦略的SWOT分析
    Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Repsol SA (REP):石油・ガス:M&Aディール及び事業提携情報
    Summary Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstream business carries out oil and natural gas exploration and production. Its downstream …
  • Brembo SpA:企業の戦略・SWOT・財務情報
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Equinox Energy Capital Ltd:電力:M&Aディール及び事業提携情報
    Summary Equinox Energy Capital Ltd (Equinox) is an investment management firm that invests in wind and renewable energy assets. The firm spans its expertise in permitting, construction and asset management. It acquires PV plants which have existing project finance, lease or mortgage financing. Equin …
  • PIK-Group:企業のM&A・事業提携・投資動向
    PIK-Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PIK-Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • IRPC Public Company Limited:企業の戦略・SWOT・財務情報
    IRPC Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary IRPC Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • American Overseas Group Limited:企業の戦略・SWOT・財務分析
    American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report Summary American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Vietnam Export Import Commercial Joint Stock Bank:企業の戦略・SWOT・財務分析
    Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report Summary Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • United India Insurance Co Ltd:企業の戦略・SWOT・財務分析
    United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary United India Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Zucara Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zucara Therapeutics Inc (Zucara Therapeutics) is a pharmaceutical company that develops novel drug therapies to prevent hypoglycemia in people with diabetes. The company’s technology is used to prevent the dangerous low blood sugar by restoring the body’s ability to counter-regulate hypoglyc …
  • ICA Gruppen AB:企業の戦略・SWOT・財務情報
    ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report Summary ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Okklo Life Sciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Okklo Life Sciences BV (Okklo) is a biopharmaceutical company that develops novel therapeutic solutions. The company offers cyclodextrin-based medicines for the treatment of neglected and orphan diseases. It also develops therapeutics for infectious diseases and lysosomal storage diseases. O …
  • Adgero Biopharmaceuticals Holdings Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Adgero Biopharmaceuticals Holdings Inc (Adgero), formerly Adgero Biopharmaceuticals Inc is a biopharmaceutical company that develops proprietary late stage photodynamic therapy platform for the treatment of oncology indications. The company’s pipeline products include REM-001. Its product is …
  • Baxter International Inc.:企業の戦略・SWOT・財務情報
    Baxter International Inc. - Strategy, SWOT and Corporate Finance Report Summary Baxter International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆